|
1
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000.
|
|
2
|
Gupta GP and Massague J: Cancer
metastasis: building a framework. Cell. 127:679–695. 2006.
|
|
3
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011.
|
|
4
|
Weinstein IB and Joe AK: Mechanisms of
disease: Oncogene addiction-a rationale for molecular targeting in
cancer therapy. Nat Clin Pract Oncol. 3:448–457. 2006.
|
|
5
|
Cancer Genome Atlas Research Network.
Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA,
Ellrott K, Shmulevich I, Sander C and Stuart JM: The Cancer Genome
Atlas Pan-Cancer analysis project. Nat Genet. 1113–1120. 2013.
|
|
6
|
Emdad L, Sarkar D, Su ZZ, et al: Astrocyte
elevated gene-1: recent insights into a novel gene involved in
tumor progression, metastasis and neurodegeneration. Pharmacol
Ther. 114:155–170. 2007.
|
|
7
|
Kwong LN and Chin L: The metastasis
problem gets stickier. Cancer Cell. 15:1–2. 2009.
|
|
8
|
Su ZZ, Kang DC, Chen Y, et al:
Identification and cloning of human astrocyte genes displaying
elevated expression after infection with HIV-1 or exposure to HIV-1
envelope glycoprotein by rapid subtraction hybridization, RaSH.
Oncogene. 21:3592–3602. 2002.
|
|
9
|
Kang DC, Su ZZ, Sarkar D, et al: Cloning
and characterization of HIV-1-inducible astrocyte elevated gene-1,
AEG-1. Gene. 353:8–15. 2005.
|
|
10
|
Brown DM and Ruoslahti E: Metadherin, a
cell surface protein in breast tumors that mediates lung
metastasis. Cancer Cell. 5:365–374. 2004.
|
|
11
|
Britt DE, Yang DF, Yang DQ, et al:
Identification of a novel protein, LYRIC, localized to tight
junctions of polarized epithelial cells. Exp Cell Res. 300:134–148.
2004.
|
|
12
|
Sutherland HG, Lam YW, Briers S, Lamond AI
and Bickmore WA: 3D3/lyric: a novel transmembrane protein of the
endoplasmic reticulum and nuclear envelope, which is also present
in the nucleolus. Exp Cell Res. 294:94–105. 2004.
|
|
13
|
Hu G, Wei Y and Kang Y: The multifaceted
role of MTDH/AEG-1 in cancer progression. Clin Cancer Res.
15:5615–5620. 2009.
|
|
14
|
Warr T, Ward S, Burrows J, et al:
Identification of extensive genomic loss and gain by comparative
genomic hybridisation in malignant astrocytoma in children and
young adults. Genes Chromosomes Cancer. 31:15–22. 2001.
|
|
15
|
Yoo BK, Emdad L, Su ZZ, et al: Astrocyte
elevated gene-1 regulates hepatocellular carcinoma development and
progression. J Clin Invest. 119:465–577. 2009.
|
|
16
|
Hu G, Chong RA, Yang Q, et al: MTDH
activation by 8q22 genomic gain promotes chemoresistance and
metastasis of poor-prognosis breast cancer. Cancer Cell. 15:9–20.
2009.
|
|
17
|
Zhou Z, Deng H, Yan W, et al: Expression
of metadherin/AEG-1 gene is positively related to orientation
chemotaxis and adhesion of human hepatocellular carcinoma cell
lines of different metastatic potentials. J Huazhong Univ Sci
Technolog Med Sci. 3:353–357. 2012.
|
|
18
|
Jiang T, Zhu A, Zhu Y and Piao D: Clinical
implications of AEG-1 in liver metastasis of colorectal cancer. Med
Oncol. 29:2858–2863. 2012.
|
|
19
|
Lee SG, Kang DC, Desalle R, Sarkar D and
Fisher PB: AEG-1/MTDH/LYRIC, the beginning: initial cloning,
structure, expression profile, and regulation of expression. Adv
Cancer Res. 120:1–38. 2013.
|
|
20
|
Sarkar D and Fisher PB: AEG-1/MTDH/LYRIC:
clinical significance. Adv Cancer Res. 120:39–74. 2013.
|
|
21
|
Lee SG, Su ZZ, Emdad L, Sarkar D and
Fisher PB: Astrocyte elevated gene-1 (AEG-1) is a target gene of
oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc.
Proc Natl Acad Sci USA. 103:17390–17395. 2006.
|
|
22
|
Lee SG, Su ZZ, Emdad L, et al: Astrocyte
elevated gene-1 activates cell survival pathways through PI3K-Akt
signaling. Oncogene. 27:1114–1121. 2008.
|
|
23
|
Ke ZF, Mao X, Zeng C, et al: AEG-1
expression characteristics in human non-small cell lung cancer and
its relationship with apoptosis. Med Oncol. 30:3832013.
|
|
24
|
Li J, Yang L, Song L, et al: Astrocyte
elevated gene-1 is a proliferation promoter in breast cancer via
suppressing transcriptional factor FOXO1. Oncogene. 28:3188–3196.
2009.
|
|
25
|
Song L, Li W, Zhang H, et al:
Over-expression of AEG-1 significantly associates with tumour
aggressiveness and poor prognosis in human non-small cell lung
cancer. J Pathol. 219:317–326. 2009.
|
|
26
|
Emdad L, Sarkar D, Su ZZ, et al:
Activation of the nuclear factor kappaB pathway by astrocyte
elevatedgene-1: implications for tumor progression and metastasis.
Cancer Res. 66:1509–1516. 2006.
|
|
27
|
Gnosa S, Shen YM, Wang CJ, et al:
Expression of AEG-1 mRNA and protein in colorectal cancer patients
and colon cancer cell lines. J Transl Med. 10:1092012.
|
|
28
|
Zhang J, Zhang Y, Liu S, et al: Metadherin
confers chemoresistance of cervical cancer cells by inducing
autophagy and activating ERK/NF-κB pathway. Tumor Biol.
34:2433–2440. 2013.
|
|
29
|
Ash SC, Yang DQ and Britt DE: LYRIC/AEG-1
overexpression modulates BCCIPalpha protein levels in prostate
tumor cells. Biochem Biophys Res Commun. 371:333–338. 2008.
|
|
30
|
Sarkar D, Park ES, Emdad L, et al:
Molecular basis of nuclear factor-kappaB activation by astrocyte
elevated gene-1. Cancer Res. 68:1478–1484. 2008.
|
|
31
|
Khuda II, Koide N, Noman AS, et al:
Astrocyte elevated gene-1 (AEG-1) is induced by lipopolysaccharide
as toll-like receptor 4 (TLR4) ligand and regulates TLR4
signalling. Immunology. 128(Suppl 1): e700–e706. 2009.
|
|
32
|
Zhao Y, Kong X, Li X, et al: Metadherin
mediates lipopolysaccharide-induced migration and invasion of
breast cancer cells. PLoS One. 6:e293632011.
|
|
33
|
Wei J, Li Z, Chen W, et al: AEG-1
participates in TGF-beta1-induced EMT through p38 MAPK activation.
Cell Biol Int. 37:1016–1021. 2013.
|
|
34
|
Ge X, Lv X, Feng L, et al: Metadherin
contributes to the pathogenesis of diffuse large B-cell lymphoma.
PLoS One. 7:e394492012.
|
|
35
|
Long M, Hao M, Dong K, et al: AEG-1
overexpression is essential for maintenance of malignant state in
human AML cells via up-regulation of Akt1 mediated by AURKA
activation. Cell Signal. 25:1438–1446. 2013.
|
|
36
|
Zhang X, Zhang N and Zhang MX: Astrocyte
elevated gene-1 induces breast cancer proliferation and invasion
through upregulating HER2/neu expression. Chin Med J (Engl).
124:3546–3550. 2011.
|
|
37
|
Emdad L, Lee SG, Su ZZ, et al: Astrocyte
elevated gene-1 (AEG-1) functions as an oncogene and regulates
angiogenesis. Proc Natl Acad Sci USA. 106:21300–21305. 2009.
|
|
38
|
Noch E, Bookland M and Khalili K:
Astrocyte-elevated gene-1 (AEG-1) induction by hypoxia and glucose
deprivation in glioblastoma. Cancer Biol Ther. 11:32–9. 2011.
|
|
39
|
Li C, Li R, Song H, et al: Significance of
AEG-1 expression in correlation with VEGF, microvessel density and
clinicopathological characteristics in triple-negative breast
cancer. J Surg Oncol. 103:184–192. 2011.
|
|
40
|
Chen D, Yoo BK, Santhekadur PK, et al:
Insulin-like growth factor-binding protein-7 functions as a
potential tumor suppressor in hepatocellular carcinoma. Clin Cancer
Res. 17:6693–6701. 2011.
|
|
41
|
Long M, Dong K, Gao P, et al:
Overexpression of astrocyte-elevated gene-1 is associated with
cervical carcinoma progression and angiogenesis. Oncol Rep.
30:1414–1422. 2013.
|
|
42
|
Li C, Liu J, Lu R, et al: AEG -1
overexpression: a novel indicator for peritoneal dissemination and
lymph node metastasis in epithelial ovarian cancers. Int J Gynecol
Cancer. 21:602–608. 2011.
|
|
43
|
Liu Y, Su Z, Li G, et al: Increased
expression of metadherin protein predicts worse disease-free and
overall survival in laryngeal squamous cell carcinoma. Int J
Cancer. 133:671–679. 2013.
|
|
44
|
Deng N and Feng Y: Expression of EphA7 and
MTDH and clinicopathological significance in the squamous cell
cancer of the tongue. Zhong Nan Da Xue Xue Bao Yi Xue Ban.
12:1195–1198. 2011.(In Chinese).
|
|
45
|
Wang F, Ke ZF, Sun SJ, et al: Oncogenic
roles of astrocyte elevated gene-1 (AEG-1) in osteosarcoma
progression and prognosis. Cancer Biol Ther. 12:539–548. 2011.
|
|
46
|
Yoo BK, Gredler R, Vozhilla N, et al:
Identification of genes conferring resistance to 5-fluorouracil.
Proc Natl Acad Sci USA. 106:12938–12943. 2009.
|
|
47
|
Yoo BK, Chen D, Su ZZ, et al: Molecular
mechanism of chemoresistance by astrocyte elevated gene-1. Cancer
Res. 70:3249–3258. 2010.
|
|
48
|
Liu H, Song X, Liu C, et al: Knockdown of
astrocyte elevated gene-1 inhibits proliferation and enhancing
chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma
cells. J Exp Clin Cancer Res. 28:192009.
|
|
49
|
Bhutia SK, Kegelman TP, Das SK, et al:
Astrocyte elevated gene-1 induces protective autophagy. Proc Natl
Acad Sci USA. 107:22243–22248. 2010.
|
|
50
|
Meng X, Thiel KW and Leslie KK: Drug
Resistance Mediated by AEG-1/MTDH/LYRIC. Adv Cancer Res.
120:135–157. 2013.
|
|
51
|
Zhao Y, Moran MS, Yang Q, et al:
Metadherin regulates radioresistance in cervical cancer cells.
Oncol Rep. 27:1520–1526. 2012.
|
|
52
|
Emdad L, Das SK, Dasgupta S, et al:
AEG-1/MTDH/LYRIC: signaling pathways, downstream genes, interacting
proteins, and regulation of tumor angiogenesis. Adv Cancer Res.
120:75–111. 2013.
|
|
53
|
Srivastava J, Siddiq A, Emdad L, et al:
Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel
insights from a mouse model. Hepatology. 56:1782–1791. 2012.
|
|
54
|
Gong Z, Liu W, You N, et al: Prognostic
significance of metadherin overexpression in hepatitis B
virus-related hepatocellular carcinoma. Oncol Rep. 27:2073–2079.
2012.
|
|
55
|
Zhu K, Dai Z, Pan Q, et al: Metadherin
promotes hepatocellular carcinoma metastasis through induction of
epithelial-mesenchymal transition. Clin Cancer Res. 17:7294–7302.
2011.
|
|
56
|
Yoo BK, Santhekadur PK, Gredler R, et al:
Increased RNA-induced silencing complex (RISC) activity contributes
to hepatocellular carcinoma. Hepatology. 53:1538–1548. 2011.
|
|
57
|
Ahn S, Hyeon J and Park CK: Metadherin is
a prognostic predictor of hepatocellular carcinoma after curative
hepatectomy. Gut Liver. 7:206–212. 2013.
|
|
58
|
Sarkar D: AEG-1/MTDH/LYRIC in Liver
Cancer. Adv Cancer Res. 120:193–221. 2013.
|
|
59
|
Tokunaga E, Nakashima Y, Yamashita N, et
al: Overexpression of metadherin/MTDH is associated with an
aggressive phenotype and a poor prognosis in invasive breast
cancer. Breast Cancer. 21:341–349. 2012.
|
|
60
|
Li X, Kong X, Huo Q, et al: Metadherin
enhances the invasiveness of breast cancer cells by inducing
epithelial to mesenchymal transition. Cancer Sci. 102:1151–1157.
2011.
|
|
61
|
Liu X, Zhang N, Li X, et al:
Identification of novel variants of metadherin in breast cancer.
PLoS One. 6:e175822011.
|
|
62
|
Wan L and Kang Y: Pleiotropic Roles of
AEG-1/MTDH/LYRIC in Breast Cancer. Adv Cancer Res. 120:113–134.
2013.
|
|
63
|
Kong X, Moran MS, Zhao Y and Yang Q:
Inhibition of metadherin sensitizes breast cancer cells to AZD6244.
Cancer Biol Ther. 13:43–49. 2012.
|
|
64
|
Zhang N, Wang X, Huo Q, et al:
MicroRNA-30a suppresses breast tumor growth and metastasis by
targeting metadherin. Oncogene. Jul 15–2013.(Epub ahead of
print).
|
|
65
|
Thirkettle HJ, Girling J, Warren AY, et
al: LYRIC/AEG-1 is targeted to different subcellular compartments
by ubiquitinylation and intrinsic nuclear localization signals.
Clin Cancer Res. 15:3003–3013. 2009.
|
|
66
|
Kikuno N, Shiina H, Urakami S, et al:
Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer
progression through upregulation of FOXO3a activity. Oncogene.
26:7647–7655. 2007.
|
|
67
|
Lee HJ, Jung DB, Sohn EJ, et al:
Inhibition of hypoxia inducible factor alpha and astrocyte-elevated
gene-1 mediates cryptotanshinone exerted antitumor activity in
hypoxic PC-3 cells. Evid Based Complement Alternat Med.
2012:3909572012.
|
|
68
|
Lee SG, Kim K, Kegelman TP, et al:
Oncogene AEG-1 promotes glioma-induced neurodegeneration by
increasing glutamate excitotoxicity. Cancer Res. 71:6514–6523.
2011.
|
|
69
|
Liu L, Wu J, Ying Z, et al: Astrocyte
elevated gene-1 upregulates matrix metalloproteinase-9 and induces
human glioma invasion. Cancer Res. 70:3750–3759. 2010.
|
|
70
|
Emdad L, Sarkar D, Lee SG, et al:
Astrocyte elevated gene-1: a novel target for human glioma therapy.
Mol Cancer Ther. 9:79–88. 2010.
|
|
71
|
Yu C, Chen K, Zheng H, et al:
Overexpression of astrocyte elevated gene-1 (AEG-1) is associated
with esophageal squamous cell carcinoma (ESCC) progression and
pathogenesis. Carcinogenesis. 30:894–901. 2009.
|
|
72
|
Chun YH, Kim SU, Park JY, et al:
Prognostic value of the 7th edition of the AJCC staging system as a
clinical staging system in patients with hepatocellular carcinoma.
Eur J Cancer. 47:2568–2575. 2011.
|
|
73
|
Ahn HS, Lee HJ, Hahn S, et al: Evaluation
of the seventh American Joint Committee on Cancer/International
Union Against Cancer Classification of gastric adenocarcinoma in
comparison with the sixth classification. Cancer. 116:5592–5598.
2010.
|
|
74
|
Jian-bo X, Hui W, Yu-long H, et al:
Astrocyte-elevated gene-1 overexpression is associated with poor
prognosis in gastric cancer. Med Oncol. 28:455–462. 2011.
|
|
75
|
Zhang CF, Xia YH, Zheng QF, et al: Effect
of silencing AEG-1 with small interfering RNA on the proliferation
and cell cycle of gastric carcinoma SGC-7901 cells. Zhonghua Zhong
Liu Za Zhi. 35:22–27. 2013.(In Chinese).
|
|
76
|
Baygi ME and Nikpour P: Deregulation of
MTDH gene expression in gastric cancer. Asian Pac J Cancer Prev.
13:2833–2836. 2012.
|
|
77
|
Blanco MA, Alečković M, Hua Y, et al:
Identification of staphylococcal nuclease domain-containing 1
(SND1) as a Metadherin-interacting protein with
metastasis-promoting functions. J Biol Chem. 286:19982–19992.
2011.
|
|
78
|
Wang N, Du X, Zang L, et al: Prognostic
impact of Metadherin-SND1 interaction in colon cancer. Mol Biol
Rep. 39:10497–10504. 2012.
|
|
79
|
Zhang F, Yang Q, Meng F, et al: Astrocyte
elevated gene-1 interacts with β-catenin and increases migration
and invasion of colorectal carcinoma. Mol Carcinog. 52:603–610.
2013.
|
|
80
|
Fong Y, Wagman L, Gonen M, et al:
Evidence-based gallbladder cancer staging: changing cancer staging
by analysis of data from the National Cancer Database. Ann Surg.
243:767–774. 2006.
|
|
81
|
Sun W, Fan YZ, Xi H, et al: Astrocyte
elevated gene-1 overexpression in human primary gallbladder
carcinomas: an unfavorable and independent prognostic factor. Oncol
Rep. 26:1133–1142. 2011.
|
|
82
|
Liu DC and Yang ZL: MTDH and EphA7 are
markers for metastasis and poor prognosis of gallbladder
adenocarcinoma. Diagn Cytopathol. 41:199–205. 2013.
|
|
83
|
Su P, Zhang Q and Yang Q:
Immunohistochemical analysis of Metadherin in proliferative and
cancerous breast tissue. Diagn Pathol. 5:382010.
|
|
84
|
Sun S, Ke Z, Wang F, et al: Overexpression
of astrocyte-elevated gene-1 is closely correlated with poor
prognosis in human non-small cell lung cancer and mediates its
metastasis through up-regulation of matrix metalloproteinase-9
expression. Hum Pathol. 43:1051–1060. 2012.
|
|
85
|
Chen W, Ke Z, Shi H, Yang S and Wang L:
Overexpression of AEG-1 in renal cell carcinoma and its correlation
with tumor nuclear grade and progression. Neoplasma. 57:522–529.
2010.
|
|
86
|
Erdem H, Oktay M, Yildirim U, Uzunlar AK
and Kayikci MA: Expression of AEG-1 and p53 and their
clinicopathological significance in malignant lesions of renal cell
carcinomas: a microarray study. Pol J Pathol. 64:28–32. 2013.
|
|
87
|
Liu B, Wu Y and Peng D: Astrocyte elevated
gene-1 regulates osteosarcoma cell invasion and chemoresistance via
endothelin-1/endothelin A receptor signaling. Oncol Lett.
5:505–510. 2013.
|
|
88
|
Li C, Li Y, Wang X, et al: Elevated
expression of astrocyte elevated gene-1 (AEG-1) is correlated with
cisplatin-based chemoresistance and shortened outcome in patients
with stages III-IV serous ovarian carcinoma. Histopathology.
60:953–963. 2012.
|
|
89
|
Yuan C, Li X, Yan S, et al: The MTDH
(−470G>A) polymorphism is associated with ovarian cancer
susceptibility. PLoS One. 7:e515612012.
|
|
90
|
Wang S, Shu JZ, Cai Y, Bao Z and Liang QM:
Establishment and characterization of MTDH knockdown by artificial
MicroRNA interference - functions as a potential tumor suppressor
in breast cancer. Asian Pac J Cancer Prev. 13:2813–2818. 2012.
|
|
91
|
Ward A, Balwierz A, Zhang JD, et al:
Re-expression of microRNA-375 reverses both tamoxifen resistance
and accompanying EMT-like properties in breast cancer. Oncogene.
32:1173–1182. 2013.
|
|
92
|
Luparello C, Longo A and Vetrano M:
Exposure to cadmium chloride influences astrocyte-elevated gene-1
(AEG-1) expression in MDA-MB231 human breast cancer cells.
Biochimie. 94:207–213. 2012.
|
|
93
|
Vartak-Sharma N and Ghorpade A: Astrocyte
elevated gene-1 regulates astrocyte responses to neural injury:
implications for reactive astrogliosis and neurodegeneration. J
Neuroinflammation. 9:1952012.
|
|
94
|
Zhang N, Wang X, Huo Q, et al: The
oncogene metadherin modulates the apoptotic pathway based on the
tumor necrosis factor superfamily member TRAIL (Tumor Necrosis
Factor-related Apoptosis-inducing Ligand) in breast cancer. J Biol
Chem. 288:9396–9407. 2013.
|
|
95
|
Liu K, Guo L, Miao L, et al: Ursolic acid
inhibits epithelial-mesenchymal transition by suppressing the
expression of astrocyte-elevated gene-1 in human nonsmall cell lung
cancer A549 cells. Anticancer Drugs. 24:494–503. 2013.
|
|
96
|
Wu C, Jin B, Chen L, et al: MiR-30d
induces apoptosis and is regulated by the Akt/FOXO pathway in renal
cell carcinoma. Cell Signal. 25:1212–1221. 2013.
|
|
97
|
Yoo BK, Emdad L, Lee SG, et al: Astrocyte
elevated gene-1 (AEG-1): A multifunctional regulator of normal and
abnormal physiology. Pharmacol Ther. 130:1–8. 2011.
|
|
98
|
Sarkar D, Emdad L, Lee SG, et al:
Astrocyte elevated gene-1: far more than just a gene regulated in
astrocytes. Cancer Res. 69:8529–8535. 2009.
|
|
99
|
Chen X, Dong K, Long M, et al: Serum
anti-AEG-1 auto-antibody is a potential novel biomarker for
malignant tumors. Oncol Lett. 4:319–323. 2012.
|
|
100
|
Qian BJ, Yan F, Li N, et al:
MTDH/AEG-1-based DNA vaccine suppresses lung metastasis and
enhances chemosensitivity to doxorubicin in breast cancer. Cancer
Immunol Immunother. 60:883–893. 2011.
|
